CM
DAWN

Caption Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Caption Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.06M Buy
282,500
+257,500
+1,030% +$3.63M 0.04% 478
2025
Q4 		$233K Buy
+25,000
New +$209K ﹤0.01% 1356
2025
Q2 		– Sell
-40,000
Closed -$317K – 1562
2025
Q1 		$317K Buy
+40,000
New +$431K ﹤0.01% 1190
2024
Q4 		– Sell
-25,000
Closed -$348K – 1535
2024
Q3 		$348K Hold
25,000
– – 0.01% 989
2024
Q2 		$345K Buy
+25,000
New +$366K 0.01% 876

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Caption Management's DAWN Position: Q2 2025 in Review

Caption Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2025, closing a stake of 18,534 shares — an estimated $127K sold.

Caption Management first reported a position in DAWN in Q2 2024 and held it in 3 quarters. The position peaked at $147K in Q1 2025. 174 funds tracked by Wall St. Rank hold DAWN as of Q2 2025.

  • Caption Management reported no remaining Day One Biopharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Caption Management sold 18,534 Day One Biopharmaceuticals shares in Q2 2025, an estimated $127K.
  • Caption Management first reported a position in Day One Biopharmaceuticals in Q2 2024 and held it in 3 quarters.
  • Caption Management's Day One Biopharmaceuticals position peaked at $147K in Q1 2025.
  • 174 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2025.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.